 CANTON, Mass., Nov. 02, 2020 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical Sports Medicine markets, today announced that the latest research on its PuraPly AM, Affinity, Apligraf, NuShield and Dermagraft product lines will be presented at the 2020 Symposium on Advanced Wound Care SAWC Fall Virtual meeting, held November 4-6. 